The preferred treatment of women with early-stage cervical cancer (FIGO IA2–IIA) is radical hysterectomy with bilateral pelvic lymphadenectomy .
The procedure is well tolerated ,  with minimal associated morbidity and rare mortality .
This report summarizes the preliminary results of the trial which closed to patient accrual in June 1994 .
MATERIALS AND METHODS .
Four centers participated in this clinical trial .
Central pathology review was not required ,  although at each institution the specific pathologic criteria for determining depth of invasion were carried out according to written guidelines .
Randomization was performed at Memorial Sloan–Kettering Cancer Center by the Department of Biostatistics using an envelope system .
Data forms were maintained in a central location ,  also at MSKCC .
The estimated duration of the trial when it opened in 1987 was 4–5 years .
The trial was closed to patient entry in June 1994 due to less than optimal accrual .
RESULTS .
Overall survival and disease-free .
There skin reaction .
DISCUSSION .
Monk and colleagues pated toxicity of cisplatin and bleomycin .
The closure of this clinical trial prior to completion of the accrual goal was disappointing .
